Newsmakers

Stephen M. Parodi, MD, and Vincent Liu, MD, both of The Permanente Medical Group, published a peer-reviewed viewpoint online in JAMA on the urgent need for public health officials and large health care systems to move from containment to mitigation of the new coronavirus that causes COVID-19.

Health care and physician leaders discuss how organizations ramp up telemedicine use during the coronavirus outbreak.

On a recent episode of NPR’s Weekend Edition Saturday, Lisa A. Jackson, MD, an internist with Washington Permanente Medical Group, shared her insights on the race among scientists to develop a vaccine for the new coronavirus that leads to COVID-19 disease.

With more cases of coronavirus (COVID-19) emerging in the United States, Permanente physicians are stepping up to serve affected communities and share important information.

Sameer Awsare, MD, FACP, associate executive director of The Permanente Medical Group (TPMG), was quoted in a recent Modern Healthcare story on the rise of concierge services and innovative, technology-based access to health care in the San Francisco Bay Area.

David E. Arterburn, MD, MPH, an internal medicine physician with the Washington Permanente Medical Group, shared his expertise with The Associated Press on the increasing number of people going back a second time for surgery to aid with weight loss.

Dan X. Li, MD, a gastroenterologist with The Permanente Medical Group in Northern California, commented in Medscape on a study by Portuguese researchers showing a link between higher endoscopic grading of gastric intestinal metaplasia and an increased risk of gastric cancer.

Richard S. Isaacs, MD, FACS, CEO and executive director of The Permanente Medical Group and co-CEO of The Permanente Federation, and Chris Grant, executive vice president and chief operating officer of the Federation, recently co-wrote an opinion piece on KevinMD.com examining 5 disruptive trends that they predict will transform and eventually improve health care in America.

Sameer Awsare, MD, associate executive director for The Permanente Medical Group, shared in Biosimilars Development how Kaiser Permanente is a leader in the use of biosimilars.